Urinary Tract Infection (UTI)



Rapid Urinary Tract Infection Diagnosis and Real-time Antimicrobial Stewardship Decision Support


Condition:   Urinary Tract Infections
Interventions:   Diagnostic Test: Rapid diagnostics alone;   Other: Real-time antimicrobial stewardship decision support
Sponsor:   Helse Møre og Romsdal HF
Not yet recruiting


7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children


Condition:   Urinary Tract Infections in Children
Interventions:   Other: Longer therapy duration;   Other: Shorter therapy duration
Sponsor:   Medical University of Warsaw
Not yet recruiting


Outcomes of Urinary Tract Infection Management by Pharmacists


Condition:   Urinary Tract Infections
Intervention:   Other: Advanced care
Sponsors:   University of Alberta;   Horizon Health Network;   New Brunswick Pharmacists' Association;   Loblaw Companies Ltd.;   Pharmasave Drugs (Atlantic) Ltd.;   Alberta Pharmacists Association;   The Jean Coutu Group (PJC) Inc.
Recruiting


A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection


Condition:   Urinary Tract Infections
Interventions:   Drug: RO7079901;   Drug: Meropenem
Sponsor:   Hoffmann-La Roche
Recruiting


Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections


Condition:   Urinary Tract Infection
Intervention:   Drug: Levofloxacin
Sponsor:   Dr. Reddy's Laboratories Limited
Recruiting


Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial


Condition:   Urinary Tract Infections
Interventions:   Drug: Arctuvan;   Drug: Fosfomycin;   Drug: Placebo to Arctuvan;   Drug: Placebo to Fosfomycin
Sponsor:   University Medical Center Goettingen
Recruiting


High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection


Condition:   Urinary Tract Infection
Interventions:   Dietary Supplement: High Strength Cranberry;   Dietary Supplement: Placebo
Sponsors:   Swisse Wellness Pty Ltd;   Commonwealth Scientific and Industrial Research Organisation, Australia
Recruiting


Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections


Condition:   Urinary Tract Infections
Intervention:   Dietary Supplement: Cranberry Extract
Sponsor:   Charite University, Berlin, Germany
Recruiting


Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women


Condition:   Urinary Tract Infections
Interventions:   Combination Product: Lactobacillus reuteri;   Dietary Supplement: Sachet with cranberry + placebo
Sponsor:   Innovacion y Desarrollo de Estrategias en Salud
Not yet recruiting


Cranberry Effect on Urinary Tract Infections


Condition:   Urinary Tract Infections
Intervention:  
Sponsor:   TriHealth Inc.
Active, not recruiting


Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections


Condition:   Urinary Tract Infections
Interventions:   Drug: Temocillin;   Drug: Cefotaxime
Sponsor:   Håkan Hanberger
Recruiting


Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children


Condition:   Urinary Tract Infections
Intervention:  
Sponsor:   Fouad Madhi
Recruiting


Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae


Condition:   Urinary Tract Infections
Intervention:   Drug: Temocillin
Sponsors:   University Hospital, Grenoble;   French National Network of Clinical Research in Infectious Diseases (RENARCI)
Recruiting


Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)


Condition:   Complicated Urinary Tract Infections
Interventions:   Drug: Ceftazidime -avibactam;   Drug: Cefepime
Sponsors:   Pfizer;   PRA Health Sciences
Recruiting


Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli


Condition:   Urinary Tract Infections
Interventions:   Drug: Cefoxitin;   Drug: imipenem
Sponsor:   Central Hospital, Nancy, France
Terminated


Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections


Condition:   Urinary Tract Infection
Interventions:   Drug: Flomoxef;   Drug: Cefepime
Sponsor:   Takeda
Terminated


Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection


Condition:   Urinary Tract Infection
Interventions:   Biological: Urine Culture;   Device: Foley Catheter Tip Culture;   Device: Scanning Electron Microscopy;   Procedure: Device Specific Adverse Event Assessment;   Procedure: Foley Catheter Insertion
Sponsors:   Baylor College of Medicine;   United States Department of Defense
Terminated


Seven vs. 14 Days Treatment for Male Urinary Tract Infection


Condition:   Urinary Tract Infections
Interventions:   Other: Longer therapy duration;   Other: Shorter therapy duration
Sponsor:   VA Office of Research and Development
Recruiting


The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children


Condition:   Urinary Tract Infections
Interventions:   Drug: Trimethoprim sulfamethoxazole, cefixime, or cephalexin;   Drug: Placebo
Sponsors:   Children's Hospital of Philadelphia;   University of Pittsburgh;   University of Pennsylvania;   Westat;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting


Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice


Condition:   Urinary Tract Infections
Intervention:  
Sponsors:   University of Oslo;   University Hospital of North Norway;   St. Olavs Hospital;   Helse Stavanger HF;   The Hospital of Vestfold;   Vestre Viken Hospital Trust;   University Hospital, Akershus;   Unilabs
Completed


Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)


Condition:   Urinary Tract Infection
Interventions:   Drug: Nitrofurantoin;   Drug: Placebo
Sponsor:   Duke University
Completed


Corticosteroids for Children With Febrile Urinary Tract Infections


Conditions:   Acute Urinary Tract Infection;   Urinary Tract Infection
Interventions:   Drug: Placebo;   Drug: Dexamethasone
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting


Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients


Condition:   Catheter-Associated Urinary Tract Infection
Interventions:   Drug: Bactrim;   Other: Placebo
Sponsors:   The Cleveland Clinic;   American Urogynecologic Society
Terminated


Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)


Condition:   Urinary Tract Infection
Interventions:   Drug: ertapenem sodium (MK0826);   Drug: Comparator: ceftriaxone sodium
Sponsor:   Merck Sharp & Dohme Corp.
Completed


A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)


Condition:   Urinary Tract Infection
Intervention:   Drug: ertapenem sodium
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Refine Your Search Advanced Search